{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:38:35Z","timestamp":1761100715598,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1991,12,1]],"date-time":"1991-12-01T00:00:00Z","timestamp":691545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1991,12,1]],"date-time":"1991-12-01T00:00:00Z","timestamp":691545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1991,12]]},"DOI":"10.1016\/0002-9343(91)90328-u","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T16:57:06Z","timestamp":1086195426000},"page":"S145-S149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S1","title":["Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis\/cervicitis"],"prefix":"10.1016","volume":"91","author":[{"given":"William J.","family":"Mogabgab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(91)90328-U_BIB1","series-title":"Principles and practice of infectious diseases","first-page":"1613","article-title":"Neisseria gonorrhoeae","author":"Handsfield","year":"1990"},{"key":"10.1016\/0002-9343(91)90328-U_BIB2","first-page":"5","volume":"32","year":"1990","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/0002-9343(91)90328-U_BIB3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.1990.03450110059027","article-title":"National surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"264","author":"Schwarcz","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/0002-9343(91)90328-U_BIB4","series-title":"Program and Abstracts of the 31st International Congress on Antimicrobial Agents and Chemotherapy","article-title":"In vitro activity of temafloxacin against Neissena gonorrhoeae exhibiting resistance to penicillin and decreased susceptibility to ceftriaxone","author":"Rice","year":"1991"},{"key":"10.1016\/0002-9343(91)90328-U_BIB5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1128\/AAC.33.10.1662","article-title":"Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects","volume":"33","author":"Hooper","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB6","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.31.11.1768","article-title":"Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones","volume":"31","author":"Hardy","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jac\/23.4.527","article-title":"In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents","volume":"23","author":"Barry","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/AAC.35.3.436","article-title":"Pharmacokinetics of temafloxacin in humans after single oral doses","volume":"35","author":"Granneman","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"volume":"vol. 7","year":"1987","series-title":"Performance standards for antimicrobial susceptibility testing","key":"10.1016\/0002-9343(91)90328-U_BIB9"},{"first-page":"956","year":"1985","author":"SAS Institute","key":"10.1016\/0002-9343(91)90328-U_BIB10"},{"key":"10.1016\/0002-9343(91)90328-U_BIB11","first-page":"160","article-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"issue":"Suppl 6C","key":"10.1016\/0002-9343(91)90328-U_BIB12","first-page":"69S","article-title":"Single-dose efficacy of ofloxacin in uncomplicated gonorrhea","volume":"87","author":"Lutz","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/0002-9343(91)90328-U_BIB13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.30.2.267","article-title":"Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men","volume":"30","author":"Roddy","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/20.1.117","article-title":"Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men","volume":"20","author":"Scott","year":"1987","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 6B","key":"10.1016\/0002-9343(91)90328-U_BIB15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(87)90616-4","article-title":"Norfloxacin in the treatment of uncomplicated gonococcal infections","volume":"82","author":"Kaplowitz","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/0002-9343(91)90328-U_BIB16","first-page":"235","article-title":"Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference","volume":"64","author":"Panikabutra","year":"1988","journal-title":"Genitourin Med"},{"key":"10.1016\/0002-9343(91)90328-U_BIB17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/AAC.33.2.167","article-title":"Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection","volume":"33","author":"Black","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB18","first-page":"247","article-title":"Results of treatment of uncomplicated urogenital gonorrhoea with enoxacin compared with ceftriaxone","volume":"8","author":"Calderon","year":"1988","journal-title":"Int J Clin Pharm Res"},{"issue":"Suppl D","key":"10.1016\/0002-9343(91)90328-U_BIB19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/22.Supplement_D.223","article-title":"Fleroxacin versus standard therapy in gonococcal urethritis","volume":"22","author":"Lassus","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/AAC.32.10.1500","article-title":"In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones","volume":"32","author":"Waites","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/0002-9343(91)90328-U_BIB21","series-title":"Program and Abstracts of the 30th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"In vitro and in vivo susceptibility of Ureaplasma urealyticum to temafloxacin HCI and doxycycline","author":"Cassell","year":"1990"},{"key":"10.1016\/0002-9343(91)90328-U_BIB22","article-title":"Efficacy of temafloxacin in the treatment of nongonococcal urethritis and cervicitis","author":"Jones","year":"1991","journal-title":"Ann Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439190328U?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:000293439190328U?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:24:55Z","timestamp":1756884295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/000293439190328U"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,12]]}},"alternative-id":["000293439190328U"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(91)90328-u","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[1991,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose oral temafloxacin versus parenteral ceftriaxone in the treatment of gonococcal urethritis\/cervicitis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(91)90328-U","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1991 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}